Connection

Walter Jones to Cost-Benefit Analysis

Back to Details
This is a "connection" page, showing publications Walter Jones has written about Cost-Benefit Analysis.
Walter Jones
Connection Strength
0.032
Cost-Benefit Analysis
  1. Comparison of Markov model and discrete-event simulation techniques for HIV. Pharmacoeconomics. 2009; 27(2):159-65.
    View in: PubMed
    Score: 0.017
  2. Cost effectiveness of lopinavir/ritonavir tablets compared with atazanavir plus ritonavir in antiretroviral-experienced patients in the UK, France, Italy and Spain. Clin Drug Investig. 2007; 27(12):807-17.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.